bsp; 1 Bultingham R, Monroe S, Nichills A. Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after singledose oral and intravenous administration. J Clin Pharmacol,1996,36:315-324. 2 James J. Mycophenolate mofetil. Lancet,1996,348:1357-1359.
3 Sugioka N, Chen SH， Hayashida K. Stability and pharmacokineric studies of a new immunosuppressant mycophenolate mofetil（RS61443）in rats. Biopharm Drug Dispos,1995,16:591-601.
4 Bijil M，Horst G. Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at risk.Annals of the Rheumatic Disease,2003,62（6）:534-539.
5 董淑兰.环磷酰胺对肾病综合征患儿性腺损害及对其子代影响的远期追踪.中华儿科杂志,2000,38（12）：759-761.
6 付元凤，刘光陵，高远赋，等.霉酚酸酯治疗儿童狼疮肾炎及难治性肾病的临床与病理.中华风湿病学杂志,2001,5（2）：128.
7 徐虹，宋善路.霉酚酸酯治疗儿童Ⅳ型狼疮性肾炎疗效观察.临床儿科杂志,2004,22（8）：554-555.
8 Burattis S, Szer IS, Spencer CH, et al. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus. Rheumatol,2001,28（9）:2103-2108.
9 张强，杨达胜.麦考酚酸酯治疗儿童顽固性过敏性紫癜.China Pharmacist,2004，7（12）：954-955.
10 Gallagher KT, Bernstein B. Juvenile rheumatoid arthritis. Curr Opin Rheumtol,1999,11（5）:372-376.
11 Lepore L, Kiren V. Autologous bone marrow transplantation versus alternative drugs
in pediatric rheumatic disease. Haematologica,2000,85（11 Suppl）:89-92. 12 Europe Mycophenolate mofetil Cooperative Study Group. Placebo controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet,1995,345:1321-1325.
13 The Tricontinental Mycophenolate mofetil Renal Transplantation Study Group. A bli
上一页 [1] [2] [3] [4] 下一页
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文